Medigen Vaccine Biologics Statistics

Total Valuation

TPEX:6547 has a market cap or net worth of TWD 14.10 billion. The enterprise value is 12.57 billion.

Market Cap	14.10B
Enterprise Value	12.57B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6547 has 328.75 million shares outstanding. The number of shares has increased by 0.06% in one year.

Current Share Class	328.75M
Shares Outstanding	328.75M
Shares Change (YoY)	+0.06%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.29%
Owned by Institutions (%)	3.22%
Float	251.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	21.29
PB Ratio	3.74
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 194.16, with an EV/FCF ratio of -172.67.

EV / Earnings	-447.61
EV / Sales	18.98
EV / EBITDA	194.16
EV / EBIT	n/a
EV / FCF	-172.67

Financial Position

The company has a current ratio of 12.61, with a Debt / Equity ratio of 0.09.

Current Ratio	12.61
Quick Ratio	9.93
Debt / Equity	0.09
Debt / EBITDA	5.17
Debt / FCF	-4.60
Interest Coverage	-6.11

Financial Efficiency

Return on equity (ROE) is -0.74% and return on invested capital (ROIC) is -0.91%.

Return on Equity (ROE)	-0.74%
Return on Assets (ROA)	-0.88%
Return on Invested Capital (ROIC)	-0.91%
Return on Capital Employed (ROCE)	-1.77%
Revenue Per Employee	6.43M
Profits Per Employee	-272,748
Employee Count	103
Asset Turnover	0.13
Inventory Turnover	0.53

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.60% in the last 52 weeks. The beta is 0.95, so TPEX:6547's price volatility has been similar to the market average.

Beta (5Y)	0.95
52-Week Price Change	-18.60%
50-Day Moving Average	49.09
200-Day Moving Average	45.41
Relative Strength Index (RSI)	33.84
Average Volume (20 Days)	1,899,489

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6547 had revenue of TWD 662.47 million and -28.09 million in losses. Loss per share was -0.09.

Revenue	662.47M
Gross Profit	426.58M
Operating Income	-71.84M
Pretax Income	-28.09M
Net Income	-28.09M
EBITDA	48.06M
EBIT	-71.84M
Loss Per Share	-0.09

Full Income Statement

Balance Sheet

The company has 1.86 billion in cash and 335.03 million in debt, giving a net cash position of 1.53 billion or 4.65 per share.

Cash & Cash Equivalents	1.86B
Total Debt	335.03M
Net Cash	1.53B
Net Cash Per Share	4.65
Equity (Book Value)	3.77B
Book Value Per Share	11.47
Working Capital	2.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -37.35 million and capital expenditures -35.47 million, giving a free cash flow of -72.82 million.

Operating Cash Flow	-37.35M
Capital Expenditures	-35.47M
Free Cash Flow	-72.82M
FCF Per Share	-0.22

Full Cash Flow Statement

Margins

Gross margin is 64.39%, with operating and profit margins of -10.84% and -4.24%.

Gross Margin	64.39%
Operating Margin	-10.84%
Pretax Margin	-4.24%
Profit Margin	-4.24%
EBITDA Margin	7.26%
EBIT Margin	-10.84%
FCF Margin	n/a

Dividends & Yields

TPEX:6547 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.06%
Shareholder Yield	n/a
Earnings Yield	-0.20%
FCF Yield	-0.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 3, 2022. It was a forward split with a ratio of 1.48280574.

Last Split Date	Aug 3, 2022
Split Type	Forward
Split Ratio	1.48280574

Scores

TPEX:6547 has an Altman Z-Score of 19.42 and a Piotroski F-Score of 3.

Altman Z-Score	19.42
Piotroski F-Score	3